Clinical Trial

Introducing a Telemedicine Strategy to Deliver Cervical Cancer Screening Results in El Salvador

Study acronym: Telemedine
Completed
View on ClinicalTrials.gov →
Summary
Telemedicine, the use of telecommunication technologies to provide healthcare services remotely, has grown exponentially in the last decade. The COVID-19 pandemic highlighted the potential of these approaches as routine clinical interactions transitioned from in-person to virtual modalities around the world. While some telemedicine applications are only feasible in high-resource settings, other types have been shown to be effective in low and middle-income countries (LMICs). Interventions that utilize mobile devices such as cellular phones and digital tablets, collectively known as mobile health or mHealth, may enable greater patient access to some services and reduce the strain on resource-limited health systems. Here we describe the use of an mHealth strategy to facilitate delivery of cervical cancer screening results in El Salvador.
Trial Details
NCT Number NCT07482306
Lead Sponsor The Cleveland Clinic
Collaborators: National Cancer Institute (NCI)
Conditions Cervical Cancer Screening
Enrollment 1,103 participants
Start Date 2024-01-31
Primary Completion 2024-01-31 (estimated)
Study Completion 2024-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-03